Cutaneous leishmaniasis: An overview

Journal of Postgraduate Medicine

Volumn 49, Issue 1, 2003, Pages 50-54

  Hepburn, Neill C ^a  

^a LINCOLN COUNTY HOSPITAL   (United Kingdom)

Author keywords

Cutaneous leishmaniasis; Stiboglucoanate; Treatment

Indexed keywords

ANTIMONY DERIVATIVE; IMIQUIMOD; IMMUNOMODULATING AGENT; KETOCONAZOLE; MEGLUMINE ANTIMONATE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; RIFAMPICIN; STIBOGLUCONATE SODIUM;

ANOREXIA; ARTHRALGIA; BONE MARROW SUPPRESSION; CLINICAL FEATURE; DOSE RESPONSE; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ECG ABNORMALITY; ENDEMIC DISEASE; EUROPE; HUMAN; INCIDENCE; LEISHMANIA BRAZILIENSIS; LEUKOPENIA; LIVER DYSFUNCTION; LIVER INJURY; MALAISE; MYALGIA; PANCREATITIS; PARASITE TRANSMISSION; PATHOLOGY; PROTOZOAL INFECTION; PSYCHODIDAE; REVIEW; SEROLOGY; SKIN BIOPSY; SKIN CULTURE; SKIN IRRITATION; SKIN LEISHMANIASIS; SKIN ULCER; SYSTEMIC DISEASE; THROMBOCYTOPENIA;

EID: 0038545460     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.928     Document Type: Review

References (32)

1. Ashford RW, Desjeux P, de Raadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today 1992;8:104-5.
2. Gonzalez R, De Sousa L, Devera R JA, Ledezema E. Seasonal and nocturnal domiciliary human landing/biting behaviour of Lutzomyia (lutzomyia) evansi and Lutzomyia (Psychoclopygus) panamensis (diptera; Psychodidae) in a periurban area of a city on the Caribbean coast of eastern Venezuela (Barcelona; Anzoategui State). Trans R Soc Trop Med Hyg 1999;93:361-4.
3. Tayeh A, Jalouk L, Cairncross S. Twenty years of cutaneous leishmaniasis in Aleppo, Syria. Trans R Soc Trop Med Hyg 1997;91:657-9.
4. Brandao-Filho SP, Campbell-Lendrum D, Brito ME, Shaw JJ, Davies CR. Epidemiological surveys confirm an increasing burden of cutaneous leishmaniasis in north-eastern Brazil. Trans R Soc Trop Med Hyg 1999;93:488-94.
5. Weigle KA, Valderrama L, Arias AL, Santrica C, Saravia NG. Leishmanin standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am J Trop Med Hyg 1991;44: 260-71.
6. Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.
7. Gilles HM (Ed). Protozoal Diseases. Arnold, London: 1999.
8. Rosenthal E, Marty P, Poizot-Martin I, Reynes J, Pratlong F, Lafeuillade A, et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 1995;89:159-62.
9. Ara M, Maillo C, Peon G, Clavel A, Cuesta J, Grasa MP et al. Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus. Br J Dermatol 1998;139:114-7.
10. Herwaldt BL, Stokes SL, Juranek DD. American cutaneous leishmaniasis in U.S. travellers. Ann Intern Med 1993;118:779-84.
11. Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Dessert Storm. N Engl J Med 1993;328:1383-7.
12. Kubba R, Al-Gindan Y. Leishmaniasis. Dermatol Clinics 1989;7:331-51.
13. Kalter DC. Cutaneous and mucocutaneous leishmaniasis. Progr Derm 1989;23:1-11.
14. Lever WF, Schamberg-Lever G. Histopathology of the skin. 7th edn. Philadelphia: Lippincott; 1990.
15. Hepburn NC, Tidman MJ, Hunter JAA. Cutaneous leishmaniasis in British troops from Belize. Br J Dermatol 1993;128:63-8.
16. Bryceson A. Therapy in Man In: Peters W, Killick-Kendrick R edrs. The leishmaniases in biology and medicine. London: Academic Press; 1987. pp. 847-907.
17. Herwaldt BL, Arana BA, Navin TR. The natural history of cutaneous leishmaniasis in Guatemala. J Infect Dis 1992;165:518-27.
18. Locksley RM, Louis JA. Immunology of leishmaniasis. Curr Opin Immunol 1992;4:413-8.
19. Kubba R, Al-Gindan Y, El-Hassan AM, Omer AHS. Clinical diagnosis of cutaneous leishmaniasis (oriental sore). J Am Acad Derm 1987;16:1183-9.
20. Navin TR, Arana FE, de Merida M, Avana BA, Castillo AL, Silvers DN. Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods. Am J Trop Med Hyg 1990;42:36-42.
21. Herwaldt BL, Arana FE, Navin TR. The natural history of cutaneous leishmaniasis in Guatemala. J Infect Dis 1992;165;518-27.
22. Evans D. Handbook on Isolation, characterisation and cryopreservation of Leishmania. Geneva: UNDP/World Bank/ WHO(TDR); 1989.
23. Biddlestone LR, Hepburn NC, McLaren KM. A clinico-pathological study of cutaneous leishmaniasis in British troops from Belize. Trans R Soc Trop Med Hyg 1994;88:672-6.
24. Andresen K, Gaafar A, El-Hassan, AM Ismail A, Dafalla M, Theander TG, et al. Evaluation of the polymerase chain reaction in the diagnosis of cutaneous leishmaniasis due to Leishmania major: a comparison with direct microscopy of smears and sections from lesions. Trans R Soc Trop Med Hyg 1996;90:133-5.
25. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R (eds). The leishmaniases in biology and medicine, vol 1. London: Academic Press; 1987.
26. Berman JD. Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy and future strategies. Rev Infect Dis 1988;10:560-86.
27. Hepburn NC, Tidman MJ, Hunter JAA. Aminosidine versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Trans R Soc Trop Med 1994;88:700-3.
28. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992;46:296-306.
29. Soto J, Toledo J, Gutierrez P, Nicholls RS, Paddilla J, Engel J, et al. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis 2001;33:e57-61.
30. WHO. Control of the leishmaniases. Technical report series 793. Geneva: WHO; 1990.
31. Uzun S, Uslular C, Yucel A, Acar MA, Ozpoyraz M, Memisoglu HR. Cutaneous leishmaniasis: evaluation of 3074 cases in the Cukurova region of Turkey. Br J Derm 1999;140:347-50.
32. Arevalo I, Ward B, Miller R, Meng TC, Najar E, Alvarez E, et al. Successful treatment of drug resistant cutaneous leishmaniasis in humans by use of Imiquimod, an immunomodulator. Clin Infect Dis 2001;33:1847-51.